From: Complement C3 as a potential NAFLD predictor in an Egyptian cohort with diabetes and/or obesity
Parameters | Concentration of complement C3 (g/L) | |
---|---|---|
R | P value | |
Age (years) | − 0.115 | 0.403 |
Body mass index (kg/m2) | 0.478 | <0.001*** |
Fibrosis-4 score | 0.234 | 0.092 |
NAFLD fibrosis score | 0.323 | 0.018* |
Hemoglobin A1c (per gm %) | − 0.138 | 0.389 |
Alanine aminotransferase (U/L) | − 0.012 | 0.934 |
Aspartate aminotransferase (U/L) | − 0.006 | 0.966 |
Albumin (g/dL) | − 0.224 | 0.107 |
Urea (mg/dL) | 0.169 | 0.246 |
Creatinine (mg/dL) | 0.327 | 0.018* |
Cholesterol (mg/dL) | 0.339 | 0.018* |
Triglycerides (mg/dL) | 0.251 | 0.085 |
Low-density lipoprotein (mg/dL) | 0.055 | 0.713 |
High-density lipoproteins (mg/dL) | − 0.129 | 0.389 |
White blood cell count (x103/μL) | 0.01 | 0.94 |
Red blood cell count (× 106/μL) | − 0.057 | 0.68 |
Hemoglobin (g/dL) | 0.121 | 0.378 |
Platelet counts (×103/μL) | − 0.076 | 0.582 |